These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6340622)

  • 1. Increased fibrinolysis and amyloidosis.
    Liebman H; Chinowsky M; Valdin J; Kenoyer G; Feinstein D
    Arch Intern Med; 1983 Apr; 143(4):678-82. PubMed ID: 6340622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV; Gertz MA; Kyle RA
    Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the ratio of the euglobulin clot lysis time and fibrinogen content in euglobulin (author's transl)].
    Matsuo T; Matsunaga K
    Rinsho Ketsueki; 1974 Oct; 15(10):1128-32. PubMed ID: 4476809
    [No Abstract]   [Full Text] [Related]  

  • 5. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage.
    Glick R; Green D; Ts'ao C; Witt WA; Yu AT; Raimondi AJ
    Neurosurgery; 1981 Oct; 9(4):398-401. PubMed ID: 7301085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.
    Hu KQ; Yu AS; Tiyyagura L; Redeker AG; Reynolds TB
    Am J Gastroenterol; 2001 May; 96(5):1581-6. PubMed ID: 11374703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolysis: studies on the significance of euglobulin clot lysis time and re-examination of its estimation method].
    Ishii S; Kimura T; Numakami A; Ito S; Azumagawa T; Kikuchi N
    Kanagawa Shigaku; 1985 Sep; 20(2):271-81. PubMed ID: 3869263
    [No Abstract]   [Full Text] [Related]  

  • 9. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotting alterations in primary systemic amyloidosis.
    Gamba G; Montani N; Anesi E; Palladini G; Capezzera M; Soldavini E; Merlini G
    Haematologica; 2000 Mar; 85(3):289-92. PubMed ID: 10702818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Haemorrhagic diathesis as an early symptom of systemic amyloidosis].
    Stammler F
    Dtsch Med Wochenschr; 2006 Jan; 131(1-2):17-21. PubMed ID: 16374737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding disorders associated with cancer dysproteinemias.
    Zangari M; Elice F; Tricot G; Fink L
    Cancer Treat Res; 2009; 148():295-304. PubMed ID: 19377931
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of breast cancer and mastectomy on fibrinolytic activity in African women.
    Famodu ES; Fakoya AA; Barhua TA; Osime CO; Egwaikhide E; Egbagbe EE; Olu-Edo AN; Osime EO
    Afr J Reprod Health; 2006 Dec; 10(3):114-9. PubMed ID: 17518138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AL amyloidosis and primary fibrinolysis. Study of the mechanism of fibrinolysis].
    Boudes P; Horellou MH; Bletry O; Bendetowicz AV; Nguyen G; Conard J; Vidal E; Godeau P; Samama M
    Ann Med Interne (Paris); 1989; 140(1):41-4. PubMed ID: 2660652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
    Chang JC; Kane KK
    Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients.
    Soares SM; Fervenza FC; Lager DJ; Gertz MA; Cosio FG; Leung N
    Am J Kidney Dis; 2008 Dec; 52(6):1079-83. PubMed ID: 18649980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: a study of fibrinolysis.
    Haan J; Kluft C; Leebeek FW; de Bart AC; Buruma OJ; Roos RA
    Thromb Haemost; 1992 Jan; 67(1):16-8. PubMed ID: 1615471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the euglobulin fibrinolysis time during interruption of pregnancy after intravenous injection of EACA].
    Howorka E; Wyrzykiewicz T
    Wiad Lek; 1968 Jul; 21(13):1129-32. PubMed ID: 5670520
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of accelerated fibrinolysis in liver disease.
    Francis RB; Feinstein DI
    Haemostasis; 1984; 14(6):460-5. PubMed ID: 6534818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cardiac amyloidosis mimicking interstitial lung disease and bleeding diathesis: a case report.
    Duygu H; Akilli A; Ozerkan F; Zoghi M; Akin M; Nazli C; Ergene O
    Heart Surg Forum; 2007; 10(3):E177-9. PubMed ID: 17389204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.